MATERIALS DEVELOPMENT INC

Arlington Heights, IL · Materials · Private

Containerless sample environment instrument with event-based data acquisition for neutron beamline research on materials under extreme temperatures

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Materials
Headquarters
Arlington Heights, IL
Total capital
$7.2M
Federal grants
$5.7M
10 awards · 2016–2022
Rank in peer group#5 of 10
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
$1.4M
3 awards · Health and Human S, NASA
Rank in Materials#151 of 1258
Granted patents
0
2 pending

Capital timeline

20082010201220142016201820202022FEDERAL ↑EQUITY ↓Cumulative $7.2M$999K$1.0M$499K$992K$1M$1.1M
2008201220162020FEDERAL ↑EQUITY ↓Cumulative $7.2M$999K$1.0M$1M$1.1M

Latest events

  • Federal contractNASA · Purchase Of One (1) Drop And Catch (dnc) Calorimeter$269K
  • Federal grantEnergy · Phase II · Extreme Temperature Sample Environment for Materials Research using Neutron Scattering$1.1M
  • Federal grantHealth and Human S · Phase II · Amorphous Pharmaceutical Product Development Using Containerless Methods$493K
  • Federal grantEnergy · Phase II · Extreme Temperature Sample Environment for Materials Research using Neutron Scattering$1M
  • Federal grantHealth and Human S · Phase II · Amorphous Pharmaceutical Product Development Using Containerless Methods$992K
  • Federal grantHealth and Human S · Phase II · Amorphous Pharmaceutical Product Development Using Containerless Methods$499K
  • Federal grantEnergy · Phase I · Extreme Temperature Sample Environment for Materials Research using Neutron Scattering$150K
Show 6 earlier federal awards
  • Federal grantEnergy · Phase II · Integrating High Performance Optics and Sample Manipulation for Extended Range X-ray PDF Measurements$1.0M
  • Federal grantHealth and Human S · Phase I · Processing amorphous pharmaceutical compounds$150K
  • Federal grantHealth and Human S · Phase I · Processing amorphous pharmaceutical compounds$150K
  • Federal grantEnergy · Phase I · Integrating High Performance Optics and Sample Manipulation for Extended Range X-ray PDF Measurements$150K
  • Federal contractHealth and Human S · TAS::75 0849::TAS Nanophase Glass Ceramic X-ray Imaging Materials$999K
  • Federal contractHealth and Human S · Biomedical (basic)$150K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 10 peers

Line = median

Materials · Instrument

  • Federal grants#5 · top 50%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 0 granted of 2
  • PendingMethod For Glass Formation And Morphology Of Products Made From Non-equilibrium Liquids By Processing In Reduced GravityUSPTOApplication 18934758
  • PendingMethod For Glass Formation And Morphology Of Products Made From Non-equilibrium Liquids By Processing In Reduced GravityUSPTOApplication 63547768

Regulatory activity · Materials

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .